摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-溴-4-叔丁基苯胺 | 103273-01-4

中文名称
2-溴-4-叔丁基苯胺
中文别名
——
英文名称
2-bromo-4-tert-butylaniline
英文别名
2-bromo-4-t-butylaniline
2-溴-4-叔丁基苯胺化学式
CAS
103273-01-4
化学式
C10H14BrN
mdl
——
分子量
228.132
InChiKey
OLKYFBNIFKQRIZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    265°C(lit.)
  • 密度:
    1.306±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    26
  • 氢给体数:
    1
  • 氢受体数:
    1

安全信息

  • 安全说明:
    S26
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2921420090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H315,H319,H335
  • 储存条件:
    室温。

SDS

SDS:035576a7252d055e1343df3b043b8c32
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Bromo-4-tert-butylaniline
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-Bromo-4-tert-butylaniline
CAS number: 103273-01-4

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H14BrN
Molecular weight: 228.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

化学性质

2-溴-4-叔丁基苯胺是一种含有溴原子和叔丁基官能团的苯胺衍生物,能够发生亲核取代反应和亲电取代反应。

用途

2-溴-4-叔丁基苯胺可用于开发新的有机光电材料;也可以用作有机催化剂或配体。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-溴-4-叔丁基苯胺4-二甲氨基吡啶磷酸 作用下, 以 氯仿N,N-二甲基甲酰胺二乙二醇 为溶剂, 反应 29.0h, 生成 3,6-二叔丁基咔唑
    参考文献:
    名称:
    芳基均偶联和胺化法合成咔唑衍生物
    摘要:
    我们通过三步法从苯胺合成了各种咔唑,总收率良好(高达48%)。该过程包括N-乙酰化,铜(0)介导的乌尔曼均偶联和酸介导的分子内胺化。它允许在基材上形成各种官能团。还证实了已开发的三步合成路线逐步扩大为咔唑。
    DOI:
    10.1055/s-0039-1690759
  • 作为产物:
    描述:
    4-叔丁基苯胺盐酸 作用下, 以 乙醇溶剂黄146 为溶剂, 反应 24.0h, 生成 2-溴-4-叔丁基苯胺
    参考文献:
    名称:
    丁二炔桥连[4的合成Ñ具有] metacyclophanes外型-annular吨丁基组
    摘要:
    通过二聚体的分子间Eglinton偶联或通过线性四聚体的分子内闭环制备具有环外叔丁基的丁二炔桥联的[4 4 ]-和[4 8 ]间环phanes 。比较[4 4 ]间环phane的1 H和13 C NMR谱与[4 8 ]环烷和二苯基丁二炔的1 H和13 C NMR谱,发现其突出的几何特征是由于三键由于线性变形而引起的。通过用硫化钠处理,以良好的产率将[4 4 ]甲基环环烷转变为[0 8 ]噻吩金属环烷。
    DOI:
    10.1016/s0040-4020(01)00779-7
点击查看最新优质反应信息

文献信息

  • Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases
    申请人:Vertex Pharmaceuticals Incorporated
    公开号:US20150231142A1
    公开(公告)日:2015-08-20
    The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.
    本发明涉及含有上皮钠通道活性抑制剂与至少一种ABC转运蛋白调节剂化合物(A式、B式、C式或D式)的药物组合物。该发明还涉及这些药物配方,以及使用这些组合物治疗CFTR介导的疾病,特别是囊性纤维化的方法。
  • Synthesis and self-association properties of diethynylbenzene macrocycles
    作者:Yoshito Tobe、Naoto Utsumi、Kazuya Kawabata、Koichiro Naemura
    DOI:10.1016/s0040-4039(97)82954-1
    日期:1996.12
    We synthesized diethynylbenzene macrocycles (DBMs), cyclic oligomers of diethynylbenzene, having functional groups in the periphery of the macrocyclic framework and investigated their self-association properties in solution resulting from π-π stacking interaction. The tetrakis-DBM having hexadecyl ester groups showed dimerization behavior not only in chloroform-d, but also in o-dichlorobenzene-d4.
    我们合成了二乙炔基苯的环状低聚物二乙炔基苯大环(DBMs),在大环骨架的外围具有官能团,并研究了它们在π-π堆积相互作用下在溶液中的自缔合特性。具有十六烷基酯基的四-DBM不仅在氯仿-d中,而且在邻-二氯苯-d 4中也表现出二聚作用。
  • Direct Tryptophols Synthesis from 2-Vinylanilines and Alkynes via C≡C Triple Bond Cleavage and Dioxygen Activation
    作者:Tao Shen、Yiqun Zhang、Yu-Feng Liang、Ning Jiao
    DOI:10.1021/jacs.6b08094
    日期:2016.10.12
    metal-free CC triple bond cleavage, dioxygen activation, and reassembly into tryptophol derivatives has been developed. This chemistry provides a novel, simple, and efficient approach to highly valuable tryptophol derivatives from simple substrates under mild conditions. The mechanistic studies may promote the discovery of new methodologies through C-C bond cleavage and dioxygen activation.
    已经开发出一种意想不到的无金属 C≡C 三键断裂、双氧活化和重新组装成色氨酸衍生物。这种化学反应提供了一种新颖、简单且有效的方法,可以在温和条件下从简单底物获得高价值的色氨酸衍生物。机理研究可能会通过 CC 键裂解和分子氧活化促进新方法的发现。
  • COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES
    申请人:Van Goor Fredrick F.
    公开号:US20110098311A1
    公开(公告)日:2011-04-28
    The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.
    本发明涉及包含上皮钠通道活性抑制剂与至少一种ABC转运蛋白调节剂化合物(A式、B式、C式或D式)的药物组合物。该发明还涉及这些药物配方,以及使用这些组合物治疗CFTR介导的疾病,特别是囊性纤维化的方法。
  • 一种含硼有机电致发光化合物及其在有机电致发光器件上的应用
    申请人:江苏三月科技股份有限公司
    公开号:CN111471064A
    公开(公告)日:2020-07-31
    本发明公开了一种含硼有机电致发光化合物及其在有机电致发光器件上的应用,属于半导体技术领域。所述含硼有机电致发光化合物选自如通式(1)所示的结构:本发明还公开了上述含硼有机电致发光化合物在有机电致发光器件上的应用。本发明化合物作为有机电致发光器件的发光层材料使用时,器件的电流效率,功率效率和外量子效率均得到很大改善;同时,对于器件寿命提升非常明显。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐